$79.75
4.42% today
NYSE, Feb 28, 04:54 pm CET
ISIN
US83444M1018
Symbol
SOLV
Index
Sector

Solventum Stock price

$83.44
+8.30 11.05% 1M
+22.89 37.80% 6M
+17.38 26.31% YTD
+3.44 4.30% 1Y
+3.44 4.30% 3Y
+3.44 4.30% 5Y
+3.44 4.30% 10Y
NYSE, Closing price Thu, Feb 27 2025
-0.60 0.71%
ISIN
US83444M1018
Symbol
SOLV
Index
Sector

Key metrics

Market capitalization $14.41b
Enterprise Value $22.20b
P/B ratio (TTM) P/B ratio 4.52
Cash position $772.00m
P/E forward 25.81
P/S forward 1.76
EV/Sales forward 2.71

Is Solventum a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Solventum Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Solventum forecast:

1x Buy
8%
10x Hold
83%
1x Sell
8%

Analyst Opinions

12 Analysts have issued a Solventum forecast:

Buy
8%
Hold
83%
Sell
8%

Financial data from Solventum

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,082 2,082
0% 0%
100%
- Direct Costs 917 917
6% 6%
44%
1,165 1,165
4% 4%
56%
- Selling and Administrative Expenses 568 568
49% 49%
27%
- Research and Development Expense 189 189
5% 5%
9%
408 408
37% 37%
20%
- Depreciation and Amortization 133 133
8% 8%
6%
EBIT (Operating Income) EBIT 275 275
45% 45%
13%
Net Profit 122 122
73% 73%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Solventum directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Solventum Stock News

Positive
The Motley Fool
about 2 hours ago
Diversified healthcare company Solventum (SOLV -0.71%) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped analysts' consensus estimates. Adjusted EPS for the quarter came in at $1.41 against an anticipated $1.31 and revenue of $2.074 billion exceeded the expected $2.050 billion.
Neutral
Seeking Alpha
about 3 hours ago
Solventum Corporation (NYSE:SOLV ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Amy Wakeham - Senior Vice President of Investor Relations and External Finance Communications Bryan Hanson - Chief Executive Officer Wayde McMillan - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler & Co. Patrick Wood - Morgan Stanley David Roman...
Positive
Reuters
about 18 hours ago
3M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.
More Solventum News

Company Profile

Solventum Corp. operates as a health care company. The company was founded on January 24, 2023 and is headquartered in Maplewood, MN.

Head office United States
CEO Bryan Hanson
Employees 22,000

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today